Directorate Change & Notice of Results
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your SUN notes
Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative technology for minimally invasive surgery, announces that further to the 19 December 2023 announcement regarding Charmaine Day's intention to step down from her role as Chief Financial Officer ("CFO"), the Company confirms that Charmaine has now left the Group. Michael Roper, an interim financial consultant, has been supporting the business since February 2024 and is now overseeing the finance function.
Michael Roper is a highly experienced financial consultant who has served as an interim CFO for a number of organisations, including others in the medtech sector. Michael will remain in place to facilitate an orderly transition process once a permanent CFO is appointed. The process to recruit a new CFO continues and a further announcement will be made in due course.
Notice of results & investor briefing
Surgical Innovations will release its audited results for the year ended 31 December 2023 on Thursday 18 April 2024.
David Marsh, Chief Executive Officer, and Jonathan Glenn, Chairman, will provide a live presentation relating to the final results via the Investor Meet Company platform on 18 April 2024 at 11.00am GMT.
https://www.investormeetcompany.com/surgical-innovations-group-plc/register-investor. Investors who already follow Surgical Innovations Group plc on the Investor Meet Company platform will automatically be invited.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.